Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Genotropin in Short Children Born Small for Gestational Ag - A Long-Term Study in Belgium

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00174421

Enrollment

Registered

2005-09-15

Start date

2001-04-30

Completion date

2005-08-31

Last updated

2007-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Disorder

Brief summary

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Interventions

DRUGTreatment with Genotropin in different dosages

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Participation in the 90-080 study

Exclusion criteria

* Any severe, acute or chronic disease * Any other identifiable reason for short stature

Design outcomes

Primary

Measure	Time frame
Final height, compared to the expected familial target height	—

Secondary

Measure	Time frame
Body weight, body mass index at final height; adverse events and assessment of hematological and clinical chemistry	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026